Abstract
Obstructive sleep apnea (OSA) is recognized as an independent cardiometabolic diseases risk factor. The mechanisms underlying this relationship are possibly mediated by intermittent hypoxia and sleep fragmentation, landmark features of OSA. Recently, the role of the gut microbiome (GM) in this scenario has been highlighted. Preliminary studies suggest that these components of OSA promote …